Effects of erythropoietin in skin wound healing are dose related

FASEB Journal

Volumn 23, Issue 9, 2009, Pages 3049-3058

  Sorg, Heiko ^a   Krueger, Christian ^a   Schulz, Torsten ^a   Menger, Michael D ^b   Schmitz, Frank ^b   Vollmar, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Apoptosis; Cell migration; Epithelialization; Microcirculation; Pericytes

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RHEOLOGY; CELL MATURATION; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; EPITHELIZATION; FIBROBLAST; HAIRLESS MOUSE; HEALING IMPAIRMENT; HEMATOCRIT; IN VITRO STUDY; KERATINOCYTE; LOW DRUG DOSE; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGENERATION; REPEATED DRUG DOSE; SINGLE DRUG DOSE; SKIN INJURY; SKINFOLD THICKNESS; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; ERYTHROPOIETIN; MICE; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; TREATMENT OUTCOME; WOUND HEALING;

ANIMALIA; MUS;

EID: 70349337888     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-109991     Document Type: Article

References (60)

1. Clark, R. A., Ghosh, K., and Tonnesen, M. G. (2007) Tissue engineering for cutaneous wounds. J. Invest. Dermatol. 127, 1018-1029
2. Dyson, M., Young, S. R., Hart, J., Lynch, J. A., and Lang, S. (1992) Comparison of the effects of moist and dry conditions on the process of angiogenesis during dermal repair. J. Invest. Dermatol. 99, 729-733 (Pubitemid 23002034)
3. Martin, P. (1997) Wound healing-aiming for perfect skin regeneration. Science 276, 75-81
4. Greenhalgh, D. G. (1998) The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 30, 1019-1030
5. Staiano-Coico, L., Higgins, P. J., Schwartz, S. B., Zimm, A. J., and Goncalves, J. (2000) Wound fluids: A reflection of the state of healing. Ostomy Wound Manage. 46, 85-93
6. Desmouliere, A., Badid, C., Lochaton-Piallat, B. M., and Gabbiani, G. (1997) Apoptosis during wound healing, fibro-contractive diseases and vascular wall injury. Int. J. Biochem. Cell Biol. 29, 19-30 (Pubitemid 27096416)
7. Desmouliere, A., Redard, M., Darby, I., and Gabbiani, G. (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146, 56-66
8. Wassermann, R. J., Polo, M., Smith, P., Wang, X., Ko, F., and Robson, M. C. (1998) Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J. Surg. Res. 75, 74-80 (Pubitemid 28247116)
9. Tredget, E. E., Nedelec, B., Scott, P. G., and Ghahary, A. (1997) Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg. Clin. North. Am. 77, 701-730 (Pubitemid 27256042)
10. Werner, S., and Grose, R. (2003) Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83, 835-870 (Pubitemid 36828927)
11. Jelkmann, W. (2004) Molecular biology of erythropoietin. Intern. Med. 43, 649-659
12. Jelkmann, W., and Wagner, K. (2004) Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann. Hematol. 83, 673-686 (Pubitemid 39440211)
13. Savino, R., and Ciliberto, G. (2004) A paradigm shift for erythropoietin: no longer a special ized growth factor, but rather an all-purpose tissue-protective agent. Cell Death Differ. 11(Suppl. 1), 2-4
14. Fisher, J. W. (2003) Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood) 228, 1-14
15. Ghezzi, P., and Brines, M. (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 11(Suppl. 1), S37-S44
16. Le Minh, K., Klemm, K., Abshagen, K., Eipel, C., Menger, M. D., and Vollmar, B. (2007) Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice. Am. J. Pathol. 170, 1954-1963 (Pubitemid 47339269)
17. Haroon, Z. A., Amin, K., Jiang, X., and Arcasoy, M. O. (2003) A novel role for erythropoietin during fibrin-induced wound-healing response. Am. J. Pathol. 163, 993-1000 (Pubitemid 37040135)
18. Sayan, H., Ozacmak, V. H., Guven, A., Aktas, R. G., and Ozacmak, I. D. (2006) Erythropoietin stimulates wound healing and angiogenesis in mice. J. Invest. Surg. 19, 163-173
19. Taylor, J. E., Belch, J. J., Henderson, I. S., and Stewart, W. K. (1996) Peripheral microcirculatory blood flow in haemodialysis patients treated with erythropoietin. Int. Angiol. 15, 33-38 (Pubitemid 26145748)
20. Sorg, H., Krueger, C., and Vollmar, B. (2007) Intravital insights in skin wound healing using the mouse dorsal skin fold chamber. J. Anat. 211, 810-818 (Pubitemid 350182608)
21. Eming, S. A., Krieg, T., and Davidson, J. M. (2007) Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514-525 (Pubitemid 46271017)
22. Heinicke, K., Baum, O., Ogunshola, O. O., Vogel, J., Stallmach, T., Wolfer, D. P., Keller, S., Weber, K., Wagner, P. D., Gassmann, M., and Djonov, V. (2006) Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R947-R956 (Pubitemid 44498434)
23. Quaschning, T., Ruschitzka, F., Stallmach, T., Shaw, S., Morawietz, H., Goettsch, W., Hermann, M., Slowinski, T., Theuring, F., Hocher, B., Lüscher, T. F., and Gassmann, M. (2003) Erythropoietin- induced excessive erythrocytosis activates the tissue endothelin system in mice. FASEB J. 17, 259-261
24. Wiessner, C., Allegrini, P. R., Ekatodramis, D., Jewell, U. R., Stallmach, T., and Gassmann, M. (2001) Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J. Cereb. Blood Flow Metab. 21, 857-864 (Pubitemid 32613540)
25. Lipsic, E., van der Meer, P., Henning, R. H., Suurmeijer, A. J., Boddeus, K. M., van Veldhuisen, D. J., van Gilst, W. H., and Schoemaker, R. G. (2004) Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J. Cardiovasc. Pharmacol. 44, 473-479 (Pubitemid 39305089)
26. Vesey, D. A., Cheung, C., Pat, B., Endre, Z., Gobe, G., and Johnson, D. W. (2004) Erythropoietin protects against ischaemic acute renal injury. Nephrol. Dial. Transplant. 19, 348-355 (Pubitemid 38195983)
27. Contaldo, C., Meier, C., Elsherbiny, A., Harder, Y., Trentz, O., Menger, M. D., and Wanner, G. A. (2007) Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice. Am. J. Physiol. Heart Circ. Physiol. 293, H274-H283
28. Sirén, A. L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., Mennini, T., Heumann, R., Cerami, A., Ehrenreich, H., and Ghezzi, P. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98, 4044-4049 (Pubitemid 32249895)
29. Bor-Kucukatay, M., Yalcin, O., Meiselman, H. J., and Baskurt, O. K. (2000) Erythropoietin-induced rheological changes of rat erythrocytes. Br. J. Haematol. 110, 82-88 (Pubitemid 30625596)
30. Kwaan, H. C., and Wang, J. (2003) Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin. Thromb. Hemost. 29, 451-458
31. Blann, A. D., and Lip, G. Y. (2001) Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb. Res. 101, 321-327
32. Roger, S. D., Baker, L. R., and Raine, A. E. (1993) Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO). Clin. Nephrol. 39, 103-110
33. Tobu, M., Iqbal, O., Fareed, D., Chatha, M., Hoppensteadt, D., Bansal, V., and Fareed, J. (2004) Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor. Clin. Appl. Thromb. Hemost. 10, 225-232 (Pubitemid 38982046)
34. Spiess, B. D., Ley, C., Body, S. C., Siegel, L. C., Stover, E. P., Maddi, R., D'Ambra, M., Jain, U., Liu, F., Herskowitz, A., Mangano, D. T., and Levin, J. (1998) Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J. Thorac. Cardiovasc. Surg. 116, 460-467
35. Yamasaki, K., Edington, H. D., McClosky, C., Tzeng, E., Lizonova, A., Kovesdi, I., Steed, D. L., and Billiar, T. R. (1998) Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 101, 967-971 (Pubitemid 28125274)
36. Moon, C., Krawczyk, M., Lakatta, E. G., and Talan, M. I. (2006) Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats. Cardiovasc. Drugs Ther. 20, 245-251 (Pubitemid 44701158)
37. Ben-Dor, I., Hardy, B., Fuchs, S., Kaganovsky, E., Kadmon, E., Sagie, A., Coleman, R., Mansur, M., Politi, B., Fraser, A, Harell, D., Okon, E., Battler, A., and Haim, M. (2007) Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model. Cardiovasc. Drugs Ther. 21, 339-346 (Pubitemid 47598928)
38. Lipsic, E., Westenbrink, B. D., van der Meer, P., van der Harst, P., Voors, A. A., van Veldhuisen, D. J., Schoemaker, R. G., and van Gilst, W. H. (2008) Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit. Eur. J. Heart Fail. 10, 22-29
39. Au, K., and Ehrlich, H. P. (2007) Does rat granulation tissue maturation involve gap junction communications? Plast. Reconstr. Surg. 120, 91-99 (Pubitemid 46956036)
40. Luster, A. D., Cardiff, R. D., MacLean, J. A., Crowe, K., and Granstein, R. D. (1998) Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc. Assoc. Am. Physicians 110, 183-196 (Pubitemid 28235170)
41. Rico, R. M., Ripamonti, R., Burns, A. L., Gamelli, R. L., and DiPietro, L. A. (2002) The effect of sepsis on wound healing. J. Surg. Res. 102, 193-197
42. Galeano, M., Altavilla, D., Cucinotta, D., Russo, G. T., Calo, M., Bitto, A., Marini, H., Marini, R., Adamo, E. B., Seminara, P., Minutoli, L., Torre, V., and Squadrito, F. (2004) Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53, 2509-2517 (Pubitemid 39145612)
43. Buemi, M., Galeano, M., Sturiale, A., Ientile, R., Crisafulli, C., Parisi, A., Catania, M., Calapai, G., Impalà, P., Aloisi, C., Squadrito, F., Altavilla, D., Bitto, A., Tuccari, G., and Frisina, N. (2004) Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock 22, 169-173 (Pubitemid 40228196)
44. Galeano, M., Altavilla, D., Bitto, A., Minutoli, L., Calò, M., Lo Cascio, P., Polito, F., Giugliano, G., Squadrito, G., Mioni, C., Giuliani, D., Venuti, F. S., and Squadrito, F. (2006) Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit. Care Med. 34, 1139-1146
45. Ashley, R. A., Dubuque, S. H., Dvorak, B., Woodward, S. S., Williams, S. K., and Kling, P. J. (2002) Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr. Res. 51, 472-478 (Pubitemid 34267318)
46. Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., Mildner-Rihm, C., Martin, H., Zeiher, A. M., and Dimmeler, S. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346 (Pubitemid 36988041)
47. Ribatti, D., Vacca, A., Roccaro, A. M., Crivellato, E., and Presta, M. (2003) Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 33, 891-896
48. Muller-Ehmsen, J., Schmidt, A., Krausgrill, B., Schwinger, R. H., and Bloch, W. (2006) Role of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthood. Am. J. Physiol. Heart Circ. Physiol. 290, H331-H340
49. Bordel, R., Laschke, M. W., Menger, M. D., and Vollmar, B. (2005) Inhibition of p53 during physiological angiogenesis in the hamster ovary does not affect extent of new vessel formation but delays vessel maturation. Cell Tissue Res. 320, 427-435 (Pubitemid 40884144)
50. Vajkoczy, P., Menger, M. D., Vollmar, B., Schilling, L., Schmiedek, P., Hirth, P., Ullrich, A., and Fong, T. A. (1999) Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia 1, 31-41
51. Arcasoy, M. O. (2008) The non-haematopoietic biological effects of erythropoietin. Br. J. Haematol. 141, 14-31
52. Furlani, D., Klopsch, C., Gäbel, R., Ugurlucan, M., Pittermann, E., Klee, D., Wagner, K., Li, W., Wang, W., Ong, L.L., Nizze, H., Titze, U., Lützow, K., Lendlein, A., Steinhoff, G. and, Ma, N. (2008) Intracardiac erythropoietin injection reveals antiinflammatory potential and improved cardiac functions detected by forced swim test. Transplant. Proc. 40, 962-966
53. Imamura, R., Okumi, M., Isaka, Y., Ichimaru, N., Moriyama, T., Imai, E., Nonomura, N., Takahara, S., and Okuyama, A. (2008) Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury. Cell Transplant. 17, 135-141 (Pubitemid 351551389)
54. Lindenblatt, N., Menger, M. D., Klar, E., and Vollmar, B. (2007) Darbepoetin-alpha does not promote microvascular thrombus formation in mice: role of eNOS-dependent protection through platelet and endothelial cell deactivation. Arterioscler. Thromb. Vasc. Biol. 27, 1191-1198 (Pubitemid 46641978)
55. Gerhardt, H., and Betsholtz, C. (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 314, 15-23
56. Hellström, M., Gerhardt, H., Kalén, M., Li, X., Eriksson, U., Wolburg, H., and Betsholtz, C. (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153, 543-553 (Pubitemid 34280141)
57. Papetti, M., and Herman, I. M. Mechanisms of normal and tumor-derived angiogenesis. (2002) Am. J. Physiol. Cell Physiol 282, C947-C970
58. Chernyavsky, A. I., Arredondo, J., Vetter, D. E., and Grando, S. A. (2007) Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization. Exp. Cell. Res. 313, 3542-3555 (Pubitemid 47404552)
59. Park, S. H., Choi, M. J., Song, I. K., Choi, S. Y., Nam, J. O., Kim, C. D., Lee, B. H., Park, R. W., Park, K. M., Kim, Y. J., Kim, I. S., Kwon, T. H., and Kim, Y. L. (2007) Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to- mesenchymal transition. J. Am. Soc. Nephrol. 18, 1497-1507
60. Hosokawa, R., Urata, M.M., Ito, Y., Bringas, P. Jr., and Chai, Y. (2005) Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing. J. Invest. Dermatol. 125, 1302-1309